Ocrelizumab shows the way forward for research into treatments for progressive forms of MS
January 28, 2016Ocrelizumab, an experimental new treatment option for MS, has had promising results in recent Phase III clinical trials for both primary progressive MS and relapsing remitting MS. To find out more, click on the link below:
Ocrelizumab shows the way forward for research into treatments for progressive forms of MS
Article courtesy of MS Research Australia www.msra.org.au